DOCSLIB.ORG

Adverse Effects on Consumer's Health Caused by Hormones Administered

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Adverse Effects on Consumer's Health Caused by Hormones Administered International Food Research Journal 25(1): 1 - 10 (February 2018) Journal homepage: http://www.ifrj.upm.edu.my Mini Review Adverse effects on consumer’s health caused by hormones administered in cattle Senthil Kumar, V., Rajan, C., Divya, P. and *Sasikumar, S. Department of Chemistry, School of Advanced Sciences, VIT University, Vellore -632014, Tamil Nadu, India Article history Abstract Received: 18 September 2016 In today’s digital age to feed this ever increasing population there is a high demand for more Received in revised form: production of food. To meet this task, artificial hormones are being used to increase the 18 December 2016 production of milk and meat. In this review, we address the controversial issue of adverse effects Accepted: 18 December 2016 of hormones being administered in cattle. Oestradiol, Progesterone, Testosterone, Zeranol, Trenbolone and Melengestrol hormones are approved by U.S. food and drug administration Keywords (FDA) for commercial use. These have been found to be used to increase the quantity of milk Recombinant bovine growth and meat in cattle but their adverse effects being observed on the consumers as they cause hormone, cancer and premature puberty in children. Similarly the utilization of recombinant bovine Milk, growth hormone (rBGH) in cattle is seen to be a burning issue as it causes cancer. Here, we Cattle meat, present a deeper insight to above mentioned content Prepuberty, Insulin like growth factor, Cancer © All Rights Reserved Introduction Hormones are chemical messengers produced by rBGH hormone (Bauman et al., 1985; Elvinger et al., glands that are used to communicate between organs 1988; Monsanto Company, 2003). However, rBGH and tissues through the circulatory system. The major does not directly cause any side effects, but act as a function of hormones is to regulate physiological and basis for increased amounts of Insulin-like Growth behavioural activities such as digestion, metabolism, Factor-1 (IGF-1) hormone. This IGF-1 hormone respiration, sensory perception, sleep, stress, growth causes health issues in human beings. Human IGF-1 and reproduction (Neave, 2007). Based on their and bovine IGF-1 are chemically similar and allows chemical structure hormones are classified into four bovine hormone to be biologically active in humans classes which include (i) Aminoacid derivatives (Vermont Public Interest Research Group, 2002). (Thyroxin), (ii)Peptides, polypeptides and proteins When a biologically active bovine IGF-1 hormone (Insulin), (iii) Eicosanoids (Prostaglandins), and (iv) is ingested by humans in higher quantity, it becomes Steroid (Testosterone) (Marieb and Hoehn, 2007). more active and dangerous substance. These synthetic hormones are beneficial to human The growth hormones Oestradiol, Progesterone, beings, but they also have adverse effects such as Testosterone (Natural) and Zeranol, Trenbolone, prostate, breast and ovarian cancer (Epstein, 1996; Melengestrol (Synthetic) have a potential risk to Bohlke et al., 1998). In this current review, we deal human health. These hormones are administered in with the hazards of rBGH in milk and side effects of cattle for growth promotion purposes. The hormone hormonal residue found in meat. residues in meat results into adverse effect on human Recombinant Bovine Growth Hormone (rBGH) health such as disrupt in human hormone balance, belongs to steroid is a transgenic substance injected causing developmental problems, interfering with into dairy cattle to increase milk production. rBGH the reproductive system and can even lead to the have potential to increase milk production from 8 to development of breast, prostate or colon cancer 12 pounds per day for a cattle. The DNA responsible to (Galbraith, 2002; Ganmaa and Sato, 2005). produce bovine growth hormone in cow is combined with a plasmid vector from E.Coli bacteria. Later, this rBGH and its mode of action is allowed to reproduce, enriches the quantity of the Bovine Growth Hormone (BGH) is a natural *Corresponding author. Email: [email protected] 2 Senthil Kumar et al./IFRJ 25(1) : 1 - 10 occurring protein produced in cows, whereas the risk of breast cancer by the association of plasma recombinant Bovine Growth Hormone (rBGH) IGF-1 and Insulin-like Growth Factor Binding is a genetically engineered, synthetic version of Protein-3 (IGFBP-3). Compared with women in the the hormone. It works through a series of different lowest tertile of IGF-1 and upper two tertiles of IGF- biological processes in cattle which is not directly 1 are the elevated risk factor for ductal carcinoma in responsible for increased milk production, but it situ (Aizu-Yokota et al., 1994). stimulates liver that initiates the release of growth hormone IGF-1. This hormone enhances the milk Prostate cancer production in cows (Vermont Public Interest IGF-1 is a mitogen for prostate epithelial cells. To Research, 2002). Further, it also found to increase the investigate associations between plasma IGF levels rate of blood flow through the mammary gland and and prostate cancer risk, a case-control study within leading to production of large number of mammary the physicians was conducted on prospectively cells. It improves the ability of existing cells to collected plasma from 152 cases and 152 controls. synthesize more milk. Moreover, it also decreases the A strong positive association was observed between capability of the body to synthesize fat and making IGF-1 levels and prostate cancer risk (Chan et al., free fatty acids available for milk production. This 1998). extends lactation periods for up to three times more rBGH has been used for past 50 years. Due to than their normal length. This process doubles the this reason, the incidence of breast cancer in U.S. metabolic stress on the cow causing lack of essential women was increased to one in eight women from nutrients such as calcium and phosphorus (Bedford, one in 20 (Green, 2002). Both low-calorie diet and 2000). It has been reported that application of rBGH low birth weights can protect against breast cancer (Ex. Recombinant Bovine Somatotropin - rBST) but also decreases the amounts of IGF-1. A study increases the amount of excreted IGF-1 in milk by was conducted showing a seven time increased 25-70% (Prosser et al., 1989; European Commission, risk of breast cancer in pre-menopausal woman 1999). with high levels of IGF-1 in their blood and a four time increase of prostate cancer in men with high Effects on human health levels of IGF-1 in their blood. rBGH may also be The existing research work has been revealed responsible for the cause of decreasing in average that rBGH does not responsible for human health age of girls in the United States showing first signs problems, but it initiates the production of IGF- of puberty and menstruation (Green, 2002). Children 1 to high levels. Their presence in milk is resistant are also at risk for abnormal development, especially to pasteurization. Consequently, the consumption their reproductive and immune systems are still in of milk from rBST treated dairy cows will increase developing stage. Premature growth stimulation is a the daily intake of bovine IGF-1 (Slaba et al., 1993; real concern with sustained intakes of high levels of European Commission, 1999). Human IGF-1 and IGF-1 (Mepham et al., 1994). bovine IGF-1 are chemically similar and allowing the bovine hormone to be biologically active in Mastitis and related side effects humans. The role of IGF-1 in cancer is supported Mastitis is an inflammation of the udder of cattle. by epidemiological studies. It reveals high levels of The risk of mastitis is 25% greater with the use of circulating IGF-1 which is associated with increased rBGH with cases being more severe and long-lasting. risk of several common cancers such as prostate, The health dangers in dairy cattle caused by rBGH breast, colon-rectum and lung (Li et al., 1998; Yu and can itself cause other serious health issues in humans Rohan, 2000; Wei et al., 2015). by consuming their milk. With a higher incidence of infection such as mastitis in cows injected with Gastrointestinal cancer rBGH, which increased the demand for the use of The combination of IGF-1 in BST-milk and IGF- antibiotics. Many people are allergic to antibiotics 1 in the human gastrointestinal lumen would augment and may find themselves in dangerous to consume intraluminal concentrations of this hormone. This their milk. Today, antibiotic resistance in bacteria is increases the possibility of local mitogenic effects on a growing concern and causing common antibiotic gut tissues (Mepham et al., 1994). medicines to become useless as bacteria becomes immune to them (Galbraith, 2002; Vermont Public Breast cancer Interest Research Group, 2002). In a study of 94 cases of premenopausal ductal carcinoma in situ and 76 controls which indicates Senthil Kumar et al./IFRJ 25(1): 1 - 10 3 Risks to human health from hormone residues in cattle meat and meat product Oestradiol benzoate, Progesterone, Testosterone propionate, Zeranol, Trenbolone acetate, and Melengestrol acetate are used to increase the meat quantity in cattle. Basically these hormone derivatives except melengestrol (MGA) are usually placed alone or in combination with other steroidal hormones in cattle as compressed pellets on their ears but MGA is given orally 0.25-0.5 mg/day (Scientific Committee on Veterinary Measures Relating to Public Health, 1999). Generally the dose contains 8-20 mg of Oestradiol benzoate, 200 mg of Progesterone, 100- Figure 1. Chemical structures of (a) Oestradiol-17ß 200 mg of Trenbolone acetate, 36 mg of Zeranol and hormone, (b) Progesterone hormone, (c) Testosterone 40-300 mg of Trenbolone acetate (Galbraith, 1997; hormone and (d) Zeranol hormone Brandt, 1997). Meat and meat products derived from Zeranol the cattle have the potential risk to human beings Zeranol (Figure 1(d)) is a natural myco-oestrogen (Galbraith, 2002). derived from zearalenone produced by different species of Fusariummolds.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Us Anti-Doping Agency
    2019U.S. ANTI-DOPING AGENCY WALLET CARDEXAMPLES OF PROHIBITED AND PERMITTED SUBSTANCES AND METHODS Effective Jan. 1 – Dec. 31, 2019 CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION) • Non-Approved Substances: investigational drugs and pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use. • Anabolic Agents: androstenediol, androstenedione, bolasterone, boldenone, clenbuterol, danazol, desoxymethyltestosterone (madol), dehydrochlormethyltestosterone (DHCMT), Prasterone (dehydroepiandrosterone, DHEA , Intrarosa) and its prohormones, drostanolone, epitestosterone, methasterone, methyl-1-testosterone, methyltestosterone (Covaryx, EEMT, Est Estrogens-methyltest DS, Methitest), nandrolone, oxandrolone, prostanozol, Selective Androgen Receptor Modulators (enobosarm, (ostarine, MK-2866), andarine, LGD-4033, RAD-140). stanozolol, testosterone and its metabolites or isomers (Androgel), THG, tibolone, trenbolone, zeranol, zilpaterol, and similar substances. • Beta-2 Agonists: All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. Most inhaled beta-2 agonists are prohibited, including arformoterol (Brovana), fenoterol, higenamine (norcoclaurine, Tinospora crispa), indacaterol (Arcapta), levalbuterol (Xopenex), metaproternol (Alupent), orciprenaline, olodaterol (Striverdi), pirbuterol (Maxair), terbutaline (Brethaire), vilanterol (Breo). The only exceptions are albuterol, formoterol, and salmeterol by a metered-dose inhaler when used
    [Show full text]
  • A10 Anabolic Steroids Hardcore Info
    CONTENTS GENERAL INFORMATION 3 Anabolic steroids – What are they? 4 How do they Work? – Aromatisation 5 More molecules – More problems 6 The side effects of anabolic steroids 7 Women and anabolic steroids 8 Injecting steroids 9 Abscesses – Needle Exchanges 10 Intramuscular injection 11 Injection sites 12 Oral steroids – Cycles – Stacking 13 Diet 14 Where do steroids come from? Spotting a counterfeit 15 Drug Information – Drug dosage STEROIDS 16 Anadrol – Andriol 17 Anavar – Deca-Durabolin 18 Dynabolon – Durabolin – Dianabol 19 Esiclene – Equipoise 20 Primobolan Depot – Proviron – Primobolan orals – Pronobol 21 Sustanon – Stromba, Strombaject – Testosterone Cypionate Testosterone Enanthate 22 Testosterone Propionate – Testosterone Suspension 23 Trenbolone Acetate – Winstrol OTHER DRUGS 24 Aldactone – Arimidex 25 Clenbuterol – Cytomel 26 Ephedrine Hydrochloride – GHB 27 Growth Hormone 28 Insulin 30 Insulin-Like Growth Factor-1 – Human Chorionic Gonadotrophin 31 Tamoxifen – Nubain – Recreational Drugs 32 Steroids and the Law 34 Glossary ANABOLIC STEROIDS People use anabolic steroids for various reasons, some use them to build muscle for their job, others just want to look good and some use them to help them in sport or body building. Whatever the reason, care needs to be taken so that as little harm is done to the body as possible because despite having muscle building effects they also have serious side effects especially when used incorrectly. WHAT ARE THEY? Anabolic steroids are man made versions of the hormone testosterone. Testosterone is the chemical in men responsible for facial hair, deepening of the voice and sex organ development, basically the masculine things Steroids are in a man. used in medicine to treat anaemia, muscle weakness after These masculine effects surgery etc, vascular are called the androgenic disorders and effects of testosterone.
    [Show full text]
  • Pharmaceutical and Veterinary Compounds and Metabolites
    PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES High quality reference materials for analytical testing of pharmaceutical and veterinary compounds and metabolites. lgcstandards.com/drehrenstorfer [email protected] LGC Quality | ISO 17034 | ISO/IEC 17025 | ISO 9001 PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES What you need to know Pharmaceutical and veterinary medicines are essential for To facilitate the fair trade of food, and to ensure a consistent human and animal welfare, but their use can leave residues and evidence-based approach to consumer protection across in both the food chain and the environment. In a 2019 survey the globe, the Codex Alimentarius Commission (“Codex”) was of EU member states, the European Food Safety Authority established in 1963. Codex is a joint agency of the FAO (Food (EFSA) found that the number one food safety concern was and Agriculture Office of the United Nations) and the WHO the misuse of antibiotics, hormones and steroids in farm (World Health Organisation). It is responsible for producing animals. This is, in part, related to the issue of growing antibiotic and maintaining the Codex Alimentarius: a compendium of resistance in humans as a result of their potential overuse in standards, guidelines and codes of practice relating to food animals. This level of concern and increasing awareness of safety. The legal framework for the authorisation, distribution the risks associated with veterinary residues entering the food and control of Veterinary Medicinal Products (VMPs) varies chain has led to many regulatory bodies increasing surveillance from country to country, but certain common principles activities for pharmaceutical and veterinary residues in food and apply which are described in the Codex guidelines.
    [Show full text]
  • Drug and Medication Classification Schedule
    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
    [Show full text]
  • Zeranol Stimulates Proliferation and Aromatase Activation in Human Breast Preadipocytes
    1014 MOLECULAR MEDICINE REPORTS 14: 1014-1018, 2016 Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes SAIYI ZHONG1, SHOUCHUN LIU2, SUHUA CHEN1, HUAJUAN LIN1, WEIMIN WANG1 and XIAOMING QIN1 1Department of Food Science, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong 524088; 2Beijing Academy of Agriculture and Forestry Science, Beijing 100097, P.R. China Received May 28, 2015; Accepted April 18, 2016 DOI: 10.3892/mmr.2016.5293 Abstract. Aromatase is a crucial enzyme for the biosynthesis One of the potential factors that contributes to breast carcino- of estrogens and is involved in the process of breast carcino- genesis is the increased exposure of epithelial cells to estrogens genesis. Concerns have been raised regarding the effects of produced locally by the tissue microenvironment (2). It is clear environmental estrogens as potential regulators of aromatase that estrogens increase mammary gland cell proliferation, expression in human breast cells. Zeranol is a non-steroidal predominantly via estrogen receptor (ER)-mediated mecha- agent with potent estrogenic activity, which is widely used as nisms in estrogen-dependent breast tumors (3,4). The synthesis a growth promoter for cattle in certain countries. The present of estrogens in breast tissue is catalyzed by the enzyme study hypothesized that aromatase expression and activity aromatase, which is encoded by the gene cytochrome P450 may be elevated by low dose zeranol exposure, providing a family 19 subfamily A member 1 (CYP19A1). Aromatase is a source of estrogens that may stimulate cell proliferation. In the cytochrome P450, which synthesizes estrogens by converting present study, primary cultured human breast preadipocytes C19 androgens to aromatic C18 estrogenic steroids, thus cata- were used as an in vitro model.
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2019 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • 2019 Prohibited List
    THE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2019 The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2019 SUBSTANCES & METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL BE CONSIDERED AS “SPECIFIED SUBSTANCES” EXCEPT SUBSTANCES IN CLASSES S1, S2, S4.4, S4.5, S6.A, AND PROHIBITED METHODS M1, M2 AND M3. PROHIBITED SUBSTANCES NON-APPROVED SUBSTANCES Mestanolone; S0 Mesterolone; Any pharmacological substance which is not Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien- addressed by any of the subsequent sections of the 3-one); List and with no current approval by any governmental Metenolone; regulatory health authority for human therapeutic use Methandriol; (e.g. drugs under pre-clinical or clinical development Methasterone (17β-hydroxy-2α,17α-dimethyl-5α- or discontinued, designer drugs, substances approved androstan-3-one); only for veterinary use) is prohibited at all times. Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien- 3-one); ANABOLIC AGENTS Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α- S1 androst-1-en-3-one); Anabolic agents are prohibited. Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en- 3-one); 1. ANABOLIC ANDROGENIC STEROIDS (AAS) Methyltestosterone; a. Exogenous*
    [Show full text]
  • Effects of Prepubertal Exposure to Xenoestrogen on Development of Estrogen Target Organs in Female CD-1 Mice
    in vivo 19: 487-494 (2005) Effects of Prepubertal Exposure to Xenoestrogen on Development of Estrogen Target Organs in Female CD-1 Mice YASUYOSHI NIKAIDO, NAOYUKI DANBARA, MIKI TSUJITA-KYUTOKU, TAKASHI YURI, NORIHISA UEHARA and AIRO TSUBURA Department of Pathology II, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan Abstract. Background: There have been no previous reports more time in the estrus phase; ZEA-treated mice had a longer comparing the effects of prepubertal xenoestrogen exposure on period of anovulatory ovary than other xenoestrogen-treated development of the reproductive tract and mammary glands in mice; however, none of the xenoestrogens tested altered the female mice. The effects of genistein (GEN), resveratrol uterine or vaginal morphology or mammary gland growth. (RES), zearalenone (ZEA), zeranol (ZER), bisphenol A (BPA) and diethylstilbestrol (DES) were examined. Materials Xenoestrogens (chemicals with estrogenic activity) are and Methods: Beginning at 15 days of age, female CD-1 mice endocrine-disrupting chemicals that include naturally were administered 4 daily subcutaneous injections of 10 occurring substances produced by plants (phytoestrogens), mg/kg/day of GEN, RES, ZEA, ZER or BPA, or 10 Ìg/kg/day molds (mycoestrogens) and man-made chemicals released of DES dissolved in dimethylsulfoxide (DMSO), or DMSO into the environment (1). They may be ingested directly in vehicle. Vaginal opening was checked; estrous cyclicity was plant material, in the tissues of animals that ingest monitored from 5, 9 or 21 weeks of age for 21 consecutive xenoestrogen-producing plants or plants infected by days; 6 animals per group were autopsied at 4, 8 and 24 weeks xenoestrogen-producing molds, or in foodstuffs contaminated of age.
    [Show full text]
  • ARCI Uniform Classification Guidelines for Foreign Substances, Or Similar State Regulatory Guidelines, Shall Be Assigned Points As Follows
    DRUG TESTING STANDARDS AND PRACTICES PROGRAM. Uniform Classification Guidelines for Foreign Substances And Recommended Penalties Model Rule. January, 2019 (V.14.0) © ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL – 2019. Association of Racing Commissioners International 2365 Harrodsburg Road- B450 Lexington, Kentucky, USA www.arci.com Page 1 of 66 Preamble to the Uniform Classification Guidelines of Foreign Substances The Preamble to the Uniform Classification Guidelines was approved by the RCI Drug Testing and Quality Assurance Program Committee (now the Drug Testing Standards and Practices Program Committee) on August 26, 1991. Minor revisions to the Preamble were made by the Drug Classification subcommittee (now the Veterinary Pharmacologists Subcommittee) on September 3, 1991. "The Uniform Classification Guidelines printed on the following pages are intended to assist stewards, hearing officers and racing commissioners in evaluating the seriousness of alleged violations of medication and prohibited substance rules in racing jurisdictions. Practicing equine veterinarians, state veterinarians, and equine pharmacologists are available and should be consulted to explain the pharmacological effects of the drugs listed in each class prior to any decisions with respect to penalities to be imposed. The ranking of drugs is based on their pharmacology, their ability to influence the outcome of a race, whether or not they have legitimate therapeutic uses in the racing horse, or other evidence that they may be used improperly. These classes of drugs are intended only as guidelines and should be employed only to assist persons adjudicating facts and opinions in understanding the seriousness of the alleged offenses. The facts of each case are always different and there may be mitigating circumstances which should always be considered.
    [Show full text]
  • Health Hazard Evaluation Report 1982-257-1571
    • ,. • • w . ~.. •. , _. !/ •.... : . .!: ..... .. -...; ~~ r ~ .. -~,. : ;., · I . f. ·· :~· JI . •. lJ . 11 r/· · ·_i. 1 ,1. 1 .. ··. 11 .·. iJ ;·. .·11 !~·" . ,-;, r~ . · IJ .• ,. -~-i1 . .. -1·, 1 . !1 !J~ · . :Health.Hazard. : HETA s2~2s7-i571 Evaluation· MA.~UFACTURI;•s CHEMISTS 1:,c• -Report . ImlllfMPOLIS., 1:m1A;t~ . .:.:._ - -.- . -·-··-- . ­ .,.. i . .. .,....·... , y ... ~­ PREFACE The Hazard Evaluations and Technical Assistance Branch of NIOSH conducts ffeld investigatfons of possible hee1th hazards in the workplace•. ·T"ese . investfgatfons are conducted under the authority of Section 20(1)(£) _of the Occupational Saftty and Htalth Act of 1970, 2S U.S.C. 669(1)(6) which_ authorizes the Secretary oJ Health anc! Human Serri~s. following a written request froc any employ,r or au~orfzed representatfve of e11ployees, to · detenrrfne whether any substance·noniilly found 1n the place of elll)loyment has potentfa11y toxi c effects fn ~ch concentrations as uHd ·_or fo1.11d. · ! • · • • ••. : . ..· The Huard Evaluation's and Technical 'Assistance B~anch also· provides, upon request, medical, nursfng, and industrial hygiene technfcal ·and consultative assistance (TA) to Feder1l, state, and local agencies; labor: industry a~d ·other groups or indfvfduals to control occupational health hazards and to prevent related trauiaa and dfsease. · · · ! . I . N@ntfon of cOlffJ)any nar.es or products does not ·constitute endorse11ent by the National Institute for Occupational Safety and Health. _ . ·- ·: . ·;, , ...... ~ ... '•' a HETA 82-257-1571 NIOSH INVESTIGATORS: • MARCH 1985 Tar-Ching Aw, MB MANUFACTURING CHEMISTS INC. Rf chard .L. Stephenson, IH INDIANAPOLIS, INDIANA Alexander B. Smith, MD Charles J~ Glueck, M.D. I. Sl.MMARY In May 1982, the National Institute for Occupational Safety and Health (NIOSH) was requested to evaluate occupational exposure to an aniaal growth-proaoter, zeranol.
    [Show full text]
  • Original Article Effects of Α-Zearalanol on Spermatogenesis and Sex Hormone Levels of Male Mice
    Int J Clin Exp Med 2015;8(11):20002-20013 www.ijcem.com /ISSN:1940-5901/IJCEM0016193 Original Article Effects of α-zearalanol on spermatogenesis and sex hormone levels of male mice Cunxiang Bo1*, Wei Zhao2*, Qiang Jia1, Zhifeng Yang1, Linlin Sai1, Fang Zhang1, Zhongjun Du1, Gongchang Yu1, Lin Xie1, Zhenling Zhang1 1Shandong Academy of Occupational Health and Occupational Medicine, Shandong Academy of Medical Sci- ences, Jinan, Shandong Province, P. R. China; 2Department of Radiation Oncology, Shandong Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Jinan, Shandong Province, P. R. China. *Equal contributors. Received September 15, 2015; Accepted November 10, 2015; Epub November 15, 2015; Published November 30, 2015 Abstract: Aims: To investigate the mechanisms of α-zearalanol (Zeranol)-induced male reproductive toxicity, the effects of Zeranol on spermatogenesis and sex hormone levels of male mice were studied. Methods: Forty healthy sexually mature male Kunming mice were randomly divided into four groups. The mice were mock-treated or treated with Zeranol 25, 50 or 100 mg/kg via oral gavage for 35 days. The epididymal sperms were counted and their morphology and motility were analyzed. The testicles were examined by light and electron microscopy. The levels of serum/testicular testosterone (T), serum follicle stimulating hormone (FSH) and serum luteinizing hormone (LH) were determined by radioimmunoassay. Results: Zeranol decreased the epididymal sperm count and sperm motility in a dose depend manner. While there were not significant differences in the sperm malformation rates between the Zeranol treated groups and the control group. Furthermore, Zeranol could decrease the weight and the organ coef- ficient of the seminal vesicles and the testicles and lead to significant pathological changes of the testicles.
    [Show full text]